PMFA
RLAY icon

Plante Moran Financial Advisors’s Relay Therapeutics RLAY Stock Holding History

Plante Moran Financial Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Hold
10,836
– – 0.01% 163
2026
Q1 		$108K Buy
10,836
+2,072
+24% +$18.5K 0.01% 220
2025
Q4 		$74.1K Buy
8,764
+6,764
+338% +$48.3K ﹤0.01% 272
2025
Q3 		$10.4K Hold
2,000
– – ﹤0.01% 544
2025
Q2 		$6.92K Buy
+2,000
New +$5.95K ﹤0.01% 611

Other funds holding RLAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Plante Moran Financial Advisors's RLAY Position: Q2 2026 in Review

Plante Moran Financial Advisors held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 10,836 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #163.

Plante Moran Financial Advisors first reported a position in RLAY in Q2 2025 and has held it in 5 quarters since. 79 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Plante Moran Financial Advisors held 10,836 shares of Relay Therapeutics worth $203K as of Q2 2026.
  • Plante Moran Financial Advisors left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up 0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #163 holding.
  • Plante Moran Financial Advisors first reported a position in Relay Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 79 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.